{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:54:37Z","timestamp":1785837277076,"version":"3.56.0"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Leukemia remains a significant contributor to cancer-related morbidity and mortality across Africa, particularly among children. Limited diagnostic capacity, late-stage presentation, inadequate treatment infrastructure, and financial barriers continue to impede early detection and curative outcomes. In response, the World Health Organization (WHO) has outlined a strategic vision under the Global Initiative for Childhood Cancer (GICC), aiming to achieve at least 60% survival for children with the most common cancers, including leukemia, by 2030. This narrative review explores the alignment between WHO\u2019s global targets and Africa\u2019s regional efforts toward leukemia control. It synthesizes current progress, identifies systemic and contextual challenges, and outlines actionable opportunities for realizing a leukemia-free Africa. Using a narrative review approach, the paper examined peer-reviewed literature, WHO policy documents, regional health strategies, and gray literature published between 2010 and 2024. Despite growing policy attention, leukemia outcomes in many African countries remain far below global targets, with survival rates for acute lymphoblastic leukemia (ALL) as low as 20% and acute myeloid leukemia (AML) often under 10% in resource-constrained settings. Achieving WHO\u2019s 2030 goal of 60% survival for children with leukemia in Africa is possible but will require urgent investment in diagnostic capacity, political commitment to universal health coverage, and integration of leukemia services into national cancer control plans. Strengthening grassroots innovations and region-specific strategies will be critical to bridging the current survival gap and building resilient leukemia care systems across the continent.<\/jats:p>","DOI":"10.1097\/ms9.0000000000003553","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T20:00:12Z","timestamp":1752177612000},"page":"5661-5677","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["World Health Organization (WHO)\u2019s vision for a leukemia-free Africa: opportunities and challenges- a narrative review"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-0161","authenticated-orcid":false,"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[{"name":"Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"R2-20251007","first-page":"180\u201398","article-title":"The nexus between obesity and leukemia progression in HIV-Positive individuals: a review","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J Hematol"},{"key":"R3-20251007","first-page":"17\u201322","article-title":"Leukaemia burden in Africa","volume":"1","author":"Obeagu","year":"2023","journal-title":"Int J Curr Res Biol Med"},{"key":"R4-20251007","first-page":"73\u201392","article-title":"The impact of body mass index (BMI) on immune function in leukemia patients living with HIV: a review","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J Immunol"},{"key":"R5-20251007","first-page":"26\u201345","article-title":"The impact of obesity on overall survival in leukemia patients living with HIV: a review","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J Lab Med"},{"key":"R8-20251007","article-title":"A vision for primary health care in the 21st century: towards universal health coverage and the sustainable development goals","year":"2018","journal-title":"World Health Org"},{"key":"R9-20251007","first-page":"2137\u201369","article-title":"An assessment of interactions between global health initiatives and country health systems","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"R10-20251007","doi-asserted-by":"crossref","first-page":"1725\u201334","DOI":"10.3109\/10428194.2013.856427","article-title":"Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing","volume":"55","author":"Kohlmann","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"9\u201316","DOI":"10.1016\/j.pathog.2015.05.004","article-title":"The impact of next generation sequencing technologies on haematological research\u2013a review","volume":"2","author":"Black","year":"2015","journal-title":"Pathogenesis"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"171\u201382","DOI":"10.1016\/j.critrevonc.2018.11.008","article-title":"Complexity of genome sequencing and reporting: next generation sequencing (NGS) technologies and implementation of precision medicine in real life","volume":"133","author":"Morganti","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"1221\u201329","DOI":"10.1093\/clinchem\/46.8.1221","article-title":"Flow cytometry: principles and clinical applications in hematology","volume":"46","author":"Brown","year":"2000","journal-title":"Clin Chem"},{"key":"R15-20251007","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2352-3026(17)30232-6","article-title":"Epidemiological patterns of leukaemia in 184 countries: a population-based study","volume":"5","author":"Miranda-Filho","year":"2018","journal-title":"Lancet Haematol"},{"key":"R16-20251007","first-page":"168","article-title":"Chronic lymphocytic leukaemia trends and features at a tertiary hospital in South Africa (2011\u20132016)","volume":"5","author":"Musaigwa","year":"2021","journal-title":"SA J Oncol"},{"key":"R17-20251007","first-page":"571\u201378","article-title":"In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes","volume":"99","author":"Opie","year":"2020","journal-title":"Ann Hematol"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1080\/13102818.2021.2011413","article-title":"Innovative technological advancements in laboratory medicine: predicting the lab of the future","volume":"36","author":"Wilson","year":"2022","journal-title":"Biotechnol Biotechnol Equip"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"717\u201325","DOI":"10.1111\/ijlh.13089","article-title":"Machine learning applications in the diagnosis of leukemia: current trends and future directions","volume":"41","author":"Salah","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"R20-20251007","doi-asserted-by":"crossref","first-page":"2529\u201337","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the international microarray innovations in leukemia study group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"511\u201326","DOI":"10.1586\/erm.12.44","article-title":"Molecular diagnosis of leukemia. Expert review of molecular diagnostics","volume":"12","author":"Mason","year":"2012","journal-title":"Expert Rev Mol Diagn"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"993\u20131012","DOI":"10.1586\/erm.10.85","article-title":"Molecular diagnosis of acute myeloid leukemia","volume":"10","author":"Watt","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"R23-20251007","doi-asserted-by":"crossref","first-page":"3807032","DOI":"10.1155\/2019\/3807032","article-title":"Genomics and precision medicine: molecular diagnostics innovations shaping the future of healthcare in Qatar","volume":"2019","author":"Al-Dewik","year":"2019","journal-title":"Adv Public Health"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"44\u201354","DOI":"10.5858\/2010-0387-RAR.1","article-title":"Multiparameter flow cytometry in the diagnosis and management of acute leukemia","volume":"135","author":"Peters","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"1899\u2013907","DOI":"10.1038\/leu.2012.121","article-title":"EuroFlow: resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine","volume":"26","author":"Van Dongen","year":"2012","journal-title":"Leukemia"},{"key":"R27-20251007","doi-asserted-by":"crossref","first-page":"39\u201345","DOI":"10.1016\/j.ymeth.2016.06.023","article-title":"Applications of imaging flow cytometry in the diagnostic assessment of acute leukaemia","volume":"112","author":"Grimwade","year":"2017","journal-title":"Methods"},{"key":"R28-20251007","first-page":"2273\u201384","article-title":"Guiding the global evolution of cytogenetic testing for hematologic malignancies","volume":"139","author":"Akkari","year":"2022","journal-title":"Blood, J Am Soc Hematol"},{"key":"R29-20251007","doi-asserted-by":"crossref","first-page":"365\u201373","DOI":"10.1111\/ejh.12603","article-title":"Leukemia diagnosis: today and tomorrow","volume":"95","author":"B\u00e9n\u00e9","year":"2015","journal-title":"Eur J Haematol"},{"key":"R30-20251007","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3324\/haematol.2018.194258","article-title":"Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing","volume":"104","author":"Mack","year":"2018","journal-title":"Haematologica"},{"key":"R31-20251007","doi-asserted-by":"crossref","first-page":"924\u201335","DOI":"10.1056\/NEJMoa2024534","article-title":"Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"N Engl J Med"},{"key":"R32-20251007","first-page":"1239","article-title":"Outcome of acute myeloid leukaemia in Nigeria: clinician\u2019s perspective","volume":"15","author":"Ogbenna","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"R33-20251007","first-page":"e43794","article-title":"A survival analysis of acute myeloid leukemia patients treated with intensive chemotherapy: a single center experience","volume":"15","author":"Jimbu","year":"2023","journal-title":"Cureus"},{"key":"R34-20251007","first-page":"1\u20139","article-title":"Evidence from ghana indicates that childhood cancer treatment in sub-saharan Africa is very cost effective: a report from the childhood cancer 2030 network","volume":"4","author":"Renner","year":"2018","journal-title":"J Glob Oncol"},{"key":"R35-20251007","doi-asserted-by":"crossref","first-page":"839835","DOI":"10.3389\/fpubh.2022.839835","article-title":"Mapping cancer in Africa: a comprehensive and comparable characterization of 34 cancer types using estimates from GLOBOCAN 2020","volume":"10","author":"Sharma","year":"2022","journal-title":"Front Public Health"},{"key":"R36-20251007","doi-asserted-by":"crossref","first-page":"25\u201343","DOI":"10.3343\/alm.2021.41.1.25","article-title":"Application of next generation sequencing in laboratory medicine","volume":"41","author":"Zhong","year":"2021","journal-title":"Ann Lab Med"},{"key":"R37-20251007","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41408-018-0148-6","article-title":"Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use","volume":"8","author":"Bacher","year":"2018","journal-title":"Blood Cancer J"},{"key":"R38-20251007","doi-asserted-by":"crossref","first-page":"7355\u201365","DOI":"10.2147\/OTT.S99807","article-title":"Next-generation sequencing: advances and applications in cancer diagnosis","volume":"9","author":"Serrat\u00ec","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R39-20251007","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3324\/haematol.2013.093765","article-title":"Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring","volume":"99","author":"Luthra","year":"2014","journal-title":"Haematologica"},{"key":"R41-20251007","doi-asserted-by":"crossref","first-page":"1939\u201352","DOI":"10.1016\/S0140-6736(18)30459-8","article-title":"Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions","volume":"391","author":"Sayed","year":"2018","journal-title":"Lancet"},{"key":"R42-20251007","doi-asserted-by":"crossref","first-page":"314\u201350","DOI":"10.1128\/CMR.00059-10","article-title":"Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities","volume":"24","author":"Parsons","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"R43-20251007","first-page":"231\u201349","article-title":"Managing the future: the special virus leukemia program and the acceleration of biomedical research","volume":"48","author":"Scheffler","year":"2014","journal-title":"Stud Hist Philos Sci C: Stud Hist Philos Biol Biomed Sci"},{"key":"R44-20251007","doi-asserted-by":"crossref","first-page":"178\u2013202","DOI":"10.1080\/10408363.2021.1997899","article-title":"Using a systematic approach to strategic innovation in laboratory medicine to bring about change","volume":"59","author":"Church","year":"2022","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R45-20251007","doi-asserted-by":"crossref","first-page":"249\u201357","DOI":"10.1515\/cclm-2024-0823","article-title":"Advancing value-based laboratory medicine","volume":"63","author":"Plebani","year":"2025","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"R46-20251007","doi-asserted-by":"crossref","first-page":"2313955","DOI":"10.1002\/adma.202313955","article-title":"Recent advances in material technology for leukemia treatments","volume":"36","author":"Li","year":"2024","journal-title":"Adv Mater"},{"key":"R47-20251007","doi-asserted-by":"crossref","first-page":"6077\u201385","DOI":"10.1182\/bloodadvances.2020002997","article-title":"Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects","volume":"4","author":"Eckardt","year":"2020","journal-title":"Blood Adv"},{"key":"R48-20251007","doi-asserted-by":"crossref","first-page":"22\u201327","DOI":"10.4314\/sokjmls.v9i2.3","article-title":"Diagnostic approach to haematologic malignancies in resource-limited settings-A review","volume":"9","author":"Samson","year":"2024","journal-title":"Sokoto J Med Lab Sci"},{"key":"R49-20251007","doi-asserted-by":"crossref","first-page":"e0232848","DOI":"10.1371\/journal.pone.0232848","article-title":"Hematological malignancies in East Africa\u2014which cancers to expect and how to provide services","volume":"15","author":"Leak","year":"2020","journal-title":"Plos One"},{"key":"R50-20251007","first-page":"5078\u201387","article-title":"Meeting the challenge of hematologic malignancies in sub-Saharan Africa. Blood","volume":"119","author":"Gopal","year":"2012","journal-title":"J Am Soc Hematol"},{"key":"R51-20251007","doi-asserted-by":"crossref","first-page":"1\u20131","DOI":"10.1007\/s11912-020-00987-8","article-title":"Access to therapy for acute myeloid leukemia in the developing world: barriers and solutions","volume":"22","author":"Meillon-Garcia","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"R52-20251007","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/QAI.0000000000000255","article-title":"Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low-and middle-income countries in Africa","volume":"67","author":"Adebamowo","year":"2014","journal-title":"JAIDS J Acquir Immune Defic Syndrom"},{"key":"R53-20251007","article-title":"Building capacity for pediatric hematological diseases in sub-saharan Africa","author":"Chirande","year":"2024","journal-title":"Blood Adv"},{"key":"R54-20251007","doi-asserted-by":"crossref","first-page":"1\u20138","DOI":"10.1109\/JTEHM.2016.2604485","article-title":"The National Institutes of Health Affordable Cancer Technologies program: improving access to resource-appropriate technologies for cancer detection, diagnosis, monitoring, and treatment in low-and middle-income countries","volume":"4","author":"Pearlman","year":"2016","journal-title":"IEEE J Transl Eng Health Med"},{"key":"R55-20251007","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s43162-021-00088-3","article-title":"Are African primary physicians suspicious enough? challenges of multiple myeloma diagnosis in Africa","volume":"33","author":"Thokerunga","year":"2021","journal-title":"Egypt J Intern Med"},{"key":"R56-20251007","doi-asserted-by":"crossref","first-page":"729\u201332","DOI":"10.1016\/S1470-2045(23)00173-0","article-title":"Addressing the childhood cancer crisis in sub-Saharan Africa","volume":"24","author":"Lubega","year":"2023","journal-title":"Lancet Oncol"},{"key":"R57-20251007","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.3390\/ijerph20064732","article-title":"Enhancing equitable access to rare disease diagnosis and treatment around the world: a review of evidence, policies, and challenges","volume":"20","author":"Adachi","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"R58-20251007","doi-asserted-by":"crossref","first-page":"13\u201323","DOI":"10.2174\/1573396312666161230145417","article-title":"Improving cancer care for children in the developing world: challenges and strategies","volume":"13","author":"Al Lamki","year":"2017","journal-title":"Curr Pediatr Rev"},{"key":"R59-20251007","doi-asserted-by":"crossref","first-page":"224\u201341","DOI":"10.1080\/08880018.2022.2117882","article-title":"Current status of African pediatric oncology education efforts aligned with the Global Initiative for Childhood Cancer","volume":"40","author":"Van Heerden","year":"2023","journal-title":"Pediatr Hematol Oncol"},{"key":"R60-20251007","doi-asserted-by":"crossref","first-page":"164\u201380","DOI":"10.1016\/j.tmrv.2011.07.006","article-title":"Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges","volume":"26","author":"Bloch","year":"2012","journal-title":"Transfus Med Rev"},{"key":"R61-20251007","doi-asserted-by":"crossref","first-page":"1\u20139","DOI":"10.1186\/s12885-016-2256-7","article-title":"Pursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural Rwanda","volume":"16","author":"Tapela","year":"2016","journal-title":"BMC Cancer"},{"key":"R62-20251007","doi-asserted-by":"crossref","first-page":"115597","DOI":"10.1016\/j.biopha.2023.115597","article-title":"Nanovaccines: a game changing approach in the fight against infectious diseases","volume":"167","author":"Priyanka","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R63-20251007","doi-asserted-by":"crossref","first-page":"6862\u201368","DOI":"10.1097\/JS9.0000000000001948","article-title":"Evolving trends in stem cell therapy: an emerging and promising approach against various diseases","volume":"110","author":"Abusalah","year":"2024","journal-title":"Int J Surg"},{"key":"R64-20251007","doi-asserted-by":"crossref","first-page":"6182\u201397","DOI":"10.1097\/JS9.0000000000001074","article-title":"Advancements and mechanisms of stem cell-based therapies for spinal cord injury in animals","volume":"110","author":"Mili","year":"2024","journal-title":"Int J Surg"},{"key":"R65-20251007","doi-asserted-by":"crossref","first-page":"152366","DOI":"10.1016\/j.aanat.2024.152366","article-title":"Exploring the potential and limitations of artificial intelligence in animal anatomy","volume":"258","author":"Choudhary","year":"2025","journal-title":"Ann Anat"},{"key":"R66-20251007","doi-asserted-by":"crossref","first-page":"152355","DOI":"10.1016\/j.aanat.2024.152355","article-title":"AI-powered techniques in anatomical imaging: impacts on veterinary diagnostics and surgery","volume":"258","author":"Vickram","year":"2025","journal-title":"Ann Anat"},{"key":"R67-20251007","first-page":"1\u20135","article-title":"The relationship between body mass index and cytogenetic abnormalities in leukemia patients with HIV: a review","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J Hematol"},{"key":"R68-20251007","first-page":"23\u201335","article-title":"The impact of BMI on treatment outcomes in leukemia patients with HIV: a review","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J Hematol"},{"key":"R69-20251007","first-page":"1","article-title":"An insight on acute myeloid leukemia: pediatric perspective","volume":"10","author":"Obeagu","year":"2022","journal-title":"J Home Page"},{"key":"R70-20251007","first-page":"39\u201354","article-title":"Exploring the Impact of body mass index on quality of life in leukemia patients living with HIV: a review","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J Hematol"},{"key":"R71-20251007","first-page":"32\u201340","article-title":"Body mass index changes during remission and relapse in leukemia patients living with HIV: a review","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J Lab Med"},{"key":"R72-20251007","first-page":"31\u201339","article-title":"Obesity and treatment-related neurotoxicity in leukemia patients with advanced HIV. AIDS: a review","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J Med Sci"},{"key":"R73-20251007","first-page":"1\u201310","article-title":"Body mass index and risk of immune reconstitution inflammatory syndrome in leukemia patients co-infected with HIV","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J Immunol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:01:19Z","timestamp":1759827679000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003553","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"2025-03-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}